the market size of bioinformatics there is a lot information that locked up in presentation data omics from latin give us your money1 just what for this simple question proves to be very difficult answer number reasons first bioinformatics2 covers multitude technologies and applications addresses diverse sector today many deals company details remain private our approach therefore correlate methods estimate should bound assuming an economic rationality adequate return on investment broadly speaking comprises small specialist firms such as incyte who sell with tools needed manage date larger companies netgenics develop software integration facilities finally over 200 drug discovery part their proprietary technology3 identifying only components bundled sales database stands at approximately 300m dominant
